A state-managed system that grants individuals access credits for nanobot therapies based on a combination of health needs, social contribution scores, and adherence to public health guidelines. This aims to ensure equitable distribution while incentivizing responsible behavior and discouraging misuse. Transparent algorithms and appeals processes are implemented to mitigate bias.